Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population
Clinical trial NCT04649021 · COMPLETED
Trial details
- NCT number
- NCT04649021
- Sponsor
- BioNTech SE
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-04
- Primary completion
- 2021-02-07
- Enrollment
- 960
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.